Conference
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study
Authors
Anees S; Mcivor A; Chapman KR; Mayers I; Rochdi D; Prefontaine D; Kaplan A
Publisher
European Respiratory Society (ERS)
Publication Date
September 15, 2018
DOI
10.1183/13993003.congress-2018.pa4380
Name of conference
Airway pharmacology and treatment